Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study

Masahiro Kagabu, Tadahiro Shoji, Kazuyuki Murakami, Hideo Omi, Tatsuya Honda, Fumiharu Miura, Yoshihito Yokoyama, Hideki Tokunaga, Tadao Takano, Tsuyoshi Ohta, Dai Shimizu, Naoki Sato, Shu Soeda, Takafumi Watanabe, Hidekazu Yamada, Hideki Mizunuma, Nobuo Yaegashi, Satoru Nagase, Toru Tase, Toru Sugiyama

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: The aim of this study was to compare the efficacy of nedaplatin-based concurrent chemoradiotherapy (CCRT) with that of cisplatin-based CCRT in patients with cervical cancer. Methods: The medical records of patients with cervical cancer who had undergone CCRT between 2003 and 2007 were retrospectively reviewed. Of these, 129 patients were treated postoperatively with CCRT (n = 52) or primary CCRT (n = 77). A total of 29 patients were treated with nedaplatin-based postoperative CCRT and 23 patients were treated with cisplatin-based postoperative CCRT. A total of 28 patients were treated with nedaplatin-based postoperative CCRT, and 49 patients were treated with cisplatin-based postoperative CCRT. Progression-free survival (PFS) and overall survival (OS) were compared between the treatment groups. Results: With postoperative CCRT, there were no significant differences in recurrence rate (P = 1.0000), PFS (log-rank: P = 0.8503), and OS (log-rank: P = 0.8926) between the two treatment groups. With primary CCRT, there were no significant differences in PFS (log-rank: P = 0.7845) and OS (log-rank: P = 0.3659). The frequency of acute toxicity was not significantly different between the cisplatin-based postoperative CCRT group and the nedaplatin-based postoperative CCRT group. Conclusions: Nedaplatin-based postoperative CCRT is an effective and well-tolerated regimen for both early-stage and advanced-stage cervical cancer patients.

Original languageEnglish
Pages (from-to)735-740
Number of pages6
JournalInternational Journal of Clinical Oncology
Volume21
Issue number4
DOIs
Publication statusPublished - 2016 Aug 1

Keywords

  • Concurrent chemoradiotherapy
  • Nedaplatin
  • Radical hysterectomy
  • Uterine cervical cancer

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study'. Together they form a unique fingerprint.

  • Cite this

    Kagabu, M., Shoji, T., Murakami, K., Omi, H., Honda, T., Miura, F., Yokoyama, Y., Tokunaga, H., Takano, T., Ohta, T., Shimizu, D., Sato, N., Soeda, S., Watanabe, T., Yamada, H., Mizunuma, H., Yaegashi, N., Nagase, S., Tase, T., & Sugiyama, T. (2016). Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study. International Journal of Clinical Oncology, 21(4), 735-740. https://doi.org/10.1007/s10147-016-0946-4